Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Press Releases

Filter articles using the following links
  • Financial press releases
  • Events & presentations
15 Apr 2020 - 17 Apr 2020

2020 Cell & Gene Meeting on the Mediterranean, Barcelona, Spain – cancelled

23 Mar 2020 - 25 Mar 2020

Bio Europe Spring, Paris, France

07 Mar 2020 - 12 Mar 2020

46th NANOS Annual Meeting, Amelia Island, Florida, US

21 January 2020

GenSight Biologics Reports its Cash Position as of December 31, 2019 and Provides Operational Update

20 January 2020

GenSight Biologics Announces its 2020 Financial Calendar

20 December 2019

GenSight Biologics Announces the Filing of its 2018 Universal Registration Document

20 December 2019

GenSight Biologics obtains €15 million in financing through a bond issuance from Kreos Capital and a reserved capital increase from Sofinnova and 3SBio

11 December 2019

GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQ™ (GS010) compared to LHON natural history

09 December 2019

The Quinze-Vingts Hospital and GenSight Biologics announce a first Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France

13 Jan 2020 - 16 Jan 2020

38th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA

  • View previous 9 articles
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 42
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page